<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Cancer Urology</journal-id><journal-title-group><journal-title xml:lang="en">Cancer Urology</journal-title><trans-title-group xml:lang="ru"><trans-title>Онкоурология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-9776</issn><issn publication-format="electronic">1996-1812</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">944</article-id><article-id pub-id-type="doi">10.17650/1726-9776-2019-15-2-143-147</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>CONGRESSES AND CONFERENCES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>СЪЕЗДЫ И КОНФЕРЕНЦИИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">34th Annual Congress of the European Association of Urology in 2019: Review of oncological urology topics</article-title><trans-title-group xml:lang="ru"><trans-title>34-й ежегодный конгресс Европейской ассоциации урологов в 2019г.: обзор онкоурологических тематик</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3528-1466</contrib-id><name-alternatives><name xml:lang="en"><surname>Arakelyan</surname><given-names>G. A.</given-names></name><name xml:lang="ru"><surname>Аракелян</surname><given-names>Г. А.</given-names></name></name-alternatives><bio xml:lang="en"><p><italic>24 Kashirskoe Shosse, Moscow 115478</italic><italic/></p></bio><bio xml:lang="ru"><p><bold>Аракелян Геворг Арменович</bold></p><p><italic>115478 </italic><italic>Москва</italic><italic>, </italic><italic>Каширское</italic><italic> </italic><italic>шоссе</italic><italic>, 24 </italic><italic/></p></bio><email>dr.arakelyan@list.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">N.N. Blokhin National Medical Research Centre of Oncology, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2019-06-30" publication-format="electronic"><day>30</day><month>06</month><year>2019</year></pub-date><volume>15</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>143</fpage><lpage>147</lpage><history><date date-type="received" iso-8601-date="2019-04-02"><day>02</day><month>04</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2019-04-10"><day>10</day><month>04</month><year>2019</year></date></history><permissions><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://oncourology.abvpress.ru/oncur/article/view/944">https://oncourology.abvpress.ru/oncur/article/view/944</self-uri><abstract xml:lang="en"><p>From 15th to 19th of March, 2019 in Barcelona was held the 34th Annual Congress of the European Association of Urology (EAU), which was attended by about 15,000 doctors from more than 120 countries. The first eau Congress was held in Padua (Italy) in 1974, it was attended by only 100 doctors. About 4,500 abstracts were sent to the Congress in Barcelona, about 1,200 of which were approved in the form of reports and poster sessions. Oncourological subjects accounted for almost half of all accepted theses. The article is devoted to the review of the most significant reports presented at the EAU Congress of 2019 on oncourological diseases.</p></abstract><trans-abstract xml:lang="ru"><p>15-19 марта 2019г. в Барселоне состоялся 34 ежегодный конгресс Европейской ассоциации урологов (European Association of Urology, EAU), в котором приняли участие врачи более чем из 120 стран.  Первый конгресс ЕАУ был проведен в городе Падуя (Италия) в 1974, где принимали участие всего 100 докторов. На конгрессе в Барселоне принимали участие около 15 000 врачей со всего мира, было направлено около 4500 тезисов, примерно 1200 из которых были одобрены в виде докладов и постерных сессий. Онкоурологическая тематика составила почти половину всех принятых тезисов. В данном отчете будут раскрыты наиболее значимые доклады по онкоурологическим заболеваниям, представленные на конгрессе ЕАУ 2019г.</p></trans-abstract><kwd-group xml:lang="en"><kwd>the European Association of Urology</kwd><kwd>prostate cancer</kwd><kwd>bladder cancer</kwd><kwd>kidney cancer</kwd><kwd>penil cancer</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>Европейская ассоциация урологов</kwd><kwd>рак предстательной железы</kwd><kwd>рак мочевого пузыря</kwd><kwd>рак почки</kwd><kwd>рак полового члена</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Méjean A., Ravaud A., Thezenas S.N. et al. Sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma. Engl J Med 2018;379(5):417–27. DOI: 10.1056/NEJMoa1803675.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Sternberg C.N., Loriot Y., James N. et al. Primary results from SAUL, a multinational single-arm safety study of atezolizumab therapy for locally ad vanced or metastatic urothelial or nonu rothelial carcinoma of the urinary tract. Eur Urol 2019. DOI: 10.1016/j.eururo.2019.03.015.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>American Society of Clinical Oncology Genitourinary Cancers Symposium, (ASCO GU), February 14–16, 2019. San Francisco, CA, 2019.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>de Groot E. EAU Congress News, 3rd edn. Barcelona, 2019; 01.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Osanto S., Alvarez Gomez de Segura C. EAU Congress News, 1st edn. Barcelona, 2019; 16.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Kamat A.M., Matulay J.T. EAU Congress News, 1st edn. Barcelona, 2019; 22.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Necchi A. EAU Congress News, 1st edn. Barcelona, 2019; 24.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Hakenberg O.W. EAU Guidelines on Penile Cancer. EAU Guidelines. Edn. presented at the EAU Annual Congress Barcelona, 2019.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Spiess P.E. EAU Congress News, 2nd edn. Barcelona, 2019; 22.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Farolfi A., Fanti S. EAU Congress News, 2nd edn. Barcelona, 2019; 15.</mixed-citation></ref></ref-list></back></article>
